CCS-HLS Atherosclerosis Research Award

The Canadian Cardiovascular Society and HLS Therapeutics are proud to present the CCS/HLS Atherosclerosis Research Award. This research award will support innovative ground-breaking clinical research projects in the area of atherosclerosis. Priority will be given to research that has the potential to advance clinical knowledge of atherosclerosis process linked to inflammation, membrane stability and biomarkers.

Two (2) awards of $15,000 each will be awarded based on an independent peer review process.

Funding begins January 2022, and research must be completed within one (1) year.

DEADLINE EXTENDED: Applications are due September 20th, 2021.

For more details, please visit our website

---

Technical Support:
If you have any questions, concerns, or difficulties during the submission process, please contact researchawards@ccs.ca.

To submit a proposal, you must login to the submission site. CCS members should use their my.ccs.ca login information, and non-members should click "Join Now" to create a guest account.